Keogh J B, McGeeney K F, Drury M I, Counihan T B, O'Donnell M D
Gut. 1978 Dec;19(12):1125-30. doi: 10.1136/gut.19.12.1125.
Pancreatic and salivary amylase/creatinine clearance ratios in patients with various degrees of renal impairment were compared with those obtained for control subjects. In chronic renal insufficiency (mean GFR 30 ml/min +/- 15 SD; n = 13) the clearance ratios for pancreatic (mean 3.5 +/- 1.85 SD) and salivary (mean 2.3 +/- 1.3 SD) amylase were significantly higher (P less than 0.05) than those in controls. Corresponding control values (n = 26) were 2.64 +/- 0.86 (pancreatic) and 1.64 +/- 0.95 (salivary). Three patients showed values above the normal limit. In the diabetic group (mean GFR 41 ml/min +/- 22 SD; n = 10) salivary amylase/creatinine clearance ratios (mean 2.36 +/- 1.55 SD) were significantly higher than in controls (P less than 0.05). Three patients showed raised values. Pancreatic amylase clearance was raised in only one of these patients. Three patients with terminal disease (mean GFR 10 ml/min) showed markedly raised (two- to threefold) clearance ratios for both salivary and pancreatic amylase. Of a total of 26 patients, eight had increased total amylase/creatinine clearance ratios. Pancreatic amylase/creatinine clearance was increased in seven patients, while nine patients showed raised salivary amylase/creatinine ratios. Patients with raised clearance ratios did not have clinical evidence of pancreatitis. We suggest that, in the presence of impaired renal function, a high amylase/creatinine clearance ratio need not be indicative of pancreatic disease.
将不同程度肾功能损害患者的胰腺和唾液淀粉酶/肌酐清除率与对照组进行比较。在慢性肾功能不全患者中(平均肾小球滤过率[GFR]为30 ml/min±15标准差;n = 13),胰腺淀粉酶(平均3.5±1.85标准差)和唾液淀粉酶(平均2.3±1.3标准差)的清除率显著高于对照组(P<0.05)。对照组相应值(n = 26)分别为2.64±0.86(胰腺)和1.64±0.95(唾液)。3例患者的值高于正常上限。糖尿病组(平均GFR 41 ml/min±22标准差;n = 10)唾液淀粉酶/肌酐清除率(平均2.36±1.55标准差)显著高于对照组(P<0.05)。3例患者的值升高。这些患者中仅1例胰腺淀粉酶清除率升高。3例终末期疾病患者(平均GFR 10 ml/min)唾液和胰腺淀粉酶的清除率均显著升高(升高2至3倍)。在总共26例患者中,8例总淀粉酶/肌酐清除率升高。7例患者胰腺淀粉酶/肌酐清除率升高,9例患者唾液淀粉酶/肌酐比值升高。清除率升高的患者无胰腺炎的临床证据。我们认为,在肾功能受损的情况下,高淀粉酶/肌酐清除率不一定提示胰腺疾病。